AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2026
Feb 18, 2026
29745_dirs_2026-02-18_07043b18-9167-4b9b-ac65-13f915c468d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2026-02-16
Reporting Person: Zakrowski Donald A (SVP, Finance, & CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-16 | Common Stock | M | 184 | — | Acquired | 3607.443 | Direct |
| 2026-02-16 | Common Stock | F | 81.553 | $1040 | Disposed | 3525.89 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-16 | Restricted Stock Unit | $ | M | 184 | Disposed | 2026-02-16 | Common Stock (184) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1728.57 | Indirect |
Footnotes
F1: The reported amount includes 7.458 shares previously withheld to satisfy tax withholding obligations arising prior to the vesting date of this award.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29